Clinical Trial Update: TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of TQB2928 injection combined with Anlotinib hydrochloride capsule for recurrent/metastatic osteosarcoma and other solid tumors was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma
• Other Solid Tumors

Drugs mentioned

• Anlotinib hydrochloride capsule (Anlotinib hydrochloride)
• TQB2928 Injection

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Osteosarcoma, Other Solid Tumors | Phase 1 | Status: TERMINATED